Delivery Order SPE2DE21D7020-SPE2D625F3PLA
- Not listed
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $14,776.70 by the Defense Health Agency's Medical Supply Chain on April 28, 2025. This fixed-price contract with economic price adjustment provisions covers the supply of 20mm synthetic material components and is scheduled for completion by May 5, 2025. The award carries no set-aside designation, indicating open competition in the federal marketplace....
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a $26,967.93 fixed-price delivery order with economic price adjustment by the Defense Health Agency's Medical Supply Chain on September 4, 2025, with an ultimate completion date of September 11, 2025. The contract, which carries no set-aside designation, covers the procurement of 20mm NG synthetic materials (referenced as "NG SYN MR US 20MM" in the award description)...
- The U.S. Defense Health Agency's Medical Supply Chain has awarded a delivery order valued at $2,995.04 to Boston Scientific Corp for NG SYN MR US 28MM supplies. The contract was awarded on July 21, 2025, with an ultimate completion date of July 28, 2025, and will be performed at Boston Scientific's facility in Marlborough, Massachusetts. This is a fixed-price delivery order with economic price adjustment provisions and carries no set-aside designation, meaning it was awarded through open...
- Boston Scientific Corp, a global medical device manufacturer headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $2,525.83 by the Defense Health Agency's Medical Supply Chain program. The contract, issued on May 13, 2025, with an ultimate completion date of May 20, 2025, is structured as a fixed-price delivery order with economic price adjustment provisions. The award involves the supply of NG SYN MR US 20MM medical devices, with performance occurring at...
- Boston Scientific Corp has been awarded a delivery order valued at $15,200.77 for the supply of 20mm synthetic material under contract number 4569292660. This fixed-price contract with economic price adjustment was issued by the Defense Health Agency's Medical Supply Chain on September 2, 2025, with an ultimate completion date of September 9, 2025. The work will be performed at Boston Scientific's facility in Marlborough, Massachusetts, where the company manufactures advanced medical devices and...
- The Defense Health Agency's Medical Supply Chain awarded a delivery order valued at $1,103.52 to Boston Scientific Corp on August 28, 2025, with an ultimate completion date of September 5, 2025. This fixed-price contract with economic price adjustment utilizes no set-aside designation, allowing Boston Scientific to compete openly in the federal marketplace. The work will be performed at Boston Scientific's facility in Marlborough, Massachusetts, where the company manufactures and distributes...
- Boston Scientific Corp has been awarded a delivery order valued at $1,975.20 by the Defense Health Agency's Medical Supply Chain division for the delivery of NG synthetic MR US 12MM medical supplies. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and carries an ultimate completion date of September 8, 2025. The award was issued on August 29, 2025, with no set-aside designation, allowing Boston Scientific to compete openly in the federal...
- Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, was awarded a fixed-price delivery order valued at $7,669.40 by the Defense Health Agency's Medical Supply Chain on July 29, 2025, with an ultimate completion date of August 5, 2025. The contract, designated as 4568924698 for NG synthetic MR US 38MM medical supplies, represents a non-competitive award with no set-aside designation. Boston Scientific will perform this work at its...
- Boston Scientific Corp, a major global medical technology provider headquartered in Marlborough, Massachusetts, was awarded a fixed-price delivery order valued at $36,734.61 by the Defense Health Agency's Medical Supply Chain on August 15, 2025, with an ultimate completion date of August 22, 2025. The contract, which utilizes economic price adjustment provisions, is classified as contract number 4569107318 and represents a 4mm synthetic material delivery to support the agency's medical supply...
- Boston Scientific Corp has been awarded a delivery order valued at $2,527.50 by the Defense Health Agency's Medical Supply Chain for the supply of 12mm synthetic material medical products. The contract, issued on August 19, 2025, with an ultimate completion date of August 26, 2025, operates under a fixed-price arrangement with economic price adjustment provisions. The work will be performed at Boston Scientific's facility in Marlborough, Massachusetts. No set-aside designation was applied to...
- SPE2DE21D7020Indefinite Delivery Contract
- SPE2DE21D7020-SPE2D625F3PLADelivery Order
The Defense Health Agency's Medical Supply Chain awarded a delivery order valued at $17,157 to Boston Scientific Corp on September 16, 2025, for the supply of 20mm synthetic material components designated as "NG SYN MR US 20MM." This fixed-price contract with economic price adjustment provisions is scheduled for completion by September 23, 2025, and will be fulfilled at Boston Scientific's facility in Marlborough, Massachusetts. The award was made through an open competition with no set-aside designation, reflecting Boston Scientific's established position as a qualified supplier within the federal healthcare marketplace. Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, provides a comprehensive portfolio of advanced medical devices and solutions to federal agencies including the Department of Veterans Affairs, Defense Health Agency, and Defense Logistics Agency. The company maintains multiple indefinite delivery vehicles and blanket purchase agreements across federal healthcare systems, positioning it as a critical supplier of specialized cardiovascular, interventional, diagnostic, and radiation treatment technologies. This delivery order represents a routine procurement action under the company's existing contractual relationships with the Defense Health Agency's Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.2k | 9/16/25 |